This article discusses the surreal appointment of Elon Musk by former President Donald Trump to oversee all drug management in the United States. It explores the implications of such a role for drug policy, addiction, and societal changes, while examining whether Musk's unique approach could lead to meaningful reform or if it merely trivializes a serious issue.